Naringenin Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cells Proliferation and Migration and Decreases Neointimal Hyperplasia in Balloon Injured Rat Carotid Arteries through Suppressing Oxidative Stress

  • Xu Changwu
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University
  • Chen Jing
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University
  • Zhang Jing
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University
  • Hu Xiaorong
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University
  • Zhou Xiaoya
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University
  • Lu Zhibing
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University
  • Jiang Hong
    Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute of Wuhan University

この論文をさがす

抄録

Proliferation and migration of vascular smooth muscle cells (VSMCs) play pivotal roles in the development of restenosis after angioplasty and oxidative stress involves both processes. Naringenin, a flavanone compound found in citrus fruits, has been widely evaluated for antioxidant activity. This study was designed to explore whether naringenin could inhibit angiotensin II-induced VSMCs proliferation and migration and decrease neointimal hyperplasia in balloon injured rat carotid arteries. VSMCs were treated with or without naringenin before stimulation with 1 µM angiotensin II and twenty-four rats were subjected to carotid arteries injury and the carotid arteries were harvested at 14 d after balloon injury. The results showed naringenin led to a significant inhibition of angiotensin II-induced VSMCs proliferation and migration. Naringenin significantly attenuated the reactive oxygen species production, increased the superoxide dismutase activity and decreased the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, reduced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) and the nuclear translocation of nuclear factor (NF)-κB p65 in angiotensin II-treated VSMCs. Moreover, naringenin decreased the ratio of neointima to media by 63.8% in balloon injured rat carotid arteries, and the serum level of 8-iso-prostaglandin F2α in naringenin-treated rats was significantly decreased. These results indicated naringenin exhibited antioxidant activity on angiotensin II-treated VSMCs and balloon injured rat carotid arteries and could be a potential protective agent for restenosis after angioplasty.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (14)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ